2022
DOI: 10.3389/fgene.2022.795844
|View full text |Cite
|
Sign up to set email alerts
|

Comprehensive Analysis of Expression and Prognostic Value of MS4As in Glioma

Abstract: Glioma is the most common malignancy of the nervous system with high mortality rates. The MS4A family members have been reported as potential prognostic biomarkers in several cancers; however, the relationship between the MS4A family and glioma has not been clearly confirmed. In our study, we explored the prognostic value of MS4As as well as their potential pro-cancer mechanisms of glioma. Using bioinformatics analysis methods based on the data from public databases, we found that the expression of MS4A4A, MS4… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 47 publications
0
12
0
Order By: Relevance
“…Studies have shown that MS4A7 has a particular prognostic value in ovarian cancer [40] and glioma [41]. Our research found that MS4A7 mainly mediates most immune-related pathways, such as immune receptor activity, but MS4A7 is down-regulated in tumor tissues, and its low expression levels indicate a worse prognosis.…”
Section: Discussionmentioning
confidence: 51%
“…Studies have shown that MS4A7 has a particular prognostic value in ovarian cancer [40] and glioma [41]. Our research found that MS4A7 mainly mediates most immune-related pathways, such as immune receptor activity, but MS4A7 is down-regulated in tumor tissues, and its low expression levels indicate a worse prognosis.…”
Section: Discussionmentioning
confidence: 51%
“…As a cell surface signaling and intracellular adaptor protein, it also plays important roles in cell proliferation and cycle regulation ( He et al, 2017 ). MS4A is abnormally expressed in GC, brain glioma, colon cancer, and other solid tumors and has been implicated in a variety of functions ( Cruse et al, 2015 ; He et al, 2017 ; Sun et al, 2018 ; Zeng et al, 2022 ). MS4A2, MS4A6, MS4A7, MS4A8, MS4A14, and MS4A15 have been established as biomarkers of the progression and prognosis of GC ( Sun et al, 2018 ).…”
Section: Discussionmentioning
confidence: 99%
“…Studies have shown that MS4A7 has a particular prognostic value in ovarian cancer[36] and glioma [37].…”
Section: Discussionmentioning
confidence: 99%